Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Johnson & Johnson

Complete the separation of the Consumer Health business

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
15 Nov 2021
Due
30 Nov 2023
Delivered
23 Aug 2023
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“The Company is targeting completion of the planned separation in 18 to 24 months”

What we found

Evidence strength A What the grades mean

Johnson & Johnson completed the separation of its Consumer Health business (Kenvue) on August 23, 2023, which falls within the 18 to 24-month timeframe specified in the original commitment.

  • A
    Johnson & Johnson 10-Q filed 2024-07-25 Regulatory filing · published 25 Jul 2024 · retrieved 3 Oct 2026 · kept permanently by the SEC · fingerprint 4c0adb41cf7d
    “The results of the Consumer Health business (previously reported as a separate business segment) have been reflected as discontinued operations in the Company’s consolidated statements of earnings as Net earnings from discontinued operations, net of taxes through August 23, 2023, the date of the exc” ✓ confirmed on the page

Market reaction: the shares moved +0.8% against the S&P 500 over the three sessions around the disclosure (24 Jul 2024 to 29 Jul 2024). What this measures

Checked 3 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Separation
Indicative materiality
Transformational rules
Action
Complete
Deliverable
Consumer Health business separation
Language
Aspirational (“aims”, “intends”)
In the company’s control
Medium
Specificity
Medium
Conditional
Yes: consultations with works councils and employee representative bodies; final approval of Johnson & Johnson’s Board of Directors; receipt of a favorable opinion and Internal Revenue Service ruling; receipt of other regulatory approvals
Depends on
Regulatory, Partner, Government

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Johnson & Johnson? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-JNJ-004290 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.